Keratinocyte TLR in Cutaneous Immunity
Keratinocyte TLR in Cutaneous Immunity
批准号:
7269366
负责人:
JOHN C ANSEL
金额:
$27.77万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2008-08-01
关键词:
Antibacterial ResponseBacteriaBacterial InfectionsBiological ModelsBiologyCessation of lifeCommunicable DiseasesCutaneousDefectDevelopmentEpidermisEpithelial CellsEpitheliumExposure toFamilyHumanImmuneImmune responseImmunityImmunosuppressive AgentsIn VitroInfectionInfectious Skin DiseasesInflammatoryInjuryLeadLeukocytesMeasuresMediatingMorbidity - disease rateMusNatural ImmunityPlayProcessProductionProteinsPseudomonas aeruginosaPublishingRangeReportingResearch PersonnelRoleSkinStagingStaphylococcus aureusStaphylococcus epidermidisTLR2 geneTLR4 geneTestingToll-like receptorsantimicrobialcommensal microbescorneal epitheliumin vivoinsightinterestkeratinocytekeratinocyte differentiationmembermicrobialnovelpathogenpathogenic bacteriaprogramsreceptorresponse
中文摘要
描述(由申请人提供):表皮是皮肤抵抗微生物感染的第一道防线。我们最近报道,人类角膜上皮细胞以及人类和小鼠角质形成细胞能够表达一个最近描述的受体家族,称为Toll样受体(TLR)。迄今为止,大多数已发表的研究都研究了白细胞中TLR的表达和功能。关于TLR在非白细胞如角质形成细胞中的作用知之甚少。在本申请中,我们将利用体外和体内小鼠模型系统来测试以下假设:1)角质细胞TLR 2和TLR 4在宿主对革兰氏(+)和革兰氏(-)病原体金黄色葡萄球菌和铜绿假单胞菌的皮肤防御中起重要作用。2)这些保护性抗细菌应答是由金黄色葡萄球菌和铜绿假单胞菌的特定组分激活角质形成细胞TLR 2和TLR 4介导的,所述特定组分启动有效的抗微生物先天免疫效应蛋白的局部表达和产生。3)角质形成细胞TLR 2和TLR 4的表达或功能缺陷将导致对S.金黄色葡萄球菌和铜绿假单胞菌,其可导致进行性皮肤感染过程,由于这些细菌病原体的全身性传播而导致发病率增加甚至死亡。这些假设将在以下具体目标中进行测试:具体目标#1:检测培养的鼠角质形成细胞中TLR 2和TLR 4响应于革兰氏(+)和革兰氏(-)细菌、源自这些细菌的结构组分以及选定的促炎剂和免疫抑制剂的表达和功能。具体目标#2:评估选定的TLR 2和TLR 4介导的培养的小鼠角质形成细胞对致病性革兰氏(+)和革兰氏(-)细菌以及源自这些细菌的结构组分的先天免疫应答。具体目标#3:确定小鼠角质形成细胞TLR 2和TLR 4在介导宿主对革兰氏(+)和革兰氏(-)细菌感染和细菌衍生成分的保护性表皮先天免疫应答中的体内作用。将鼠角质形成细胞对病原菌的反应与对皮肤真菌的反应进行比较,并在人角质形成细胞中进行确认。我们相信,我们的研究将导致对皮肤先天免疫和皮肤中广泛的炎症和感染性疾病的管理的新见解。
英文摘要
DESCRIPTION (provided by applicant): The epidermis is the first line of defense against microbial infections of the skin. We recently reported that human corneal epithelial cells as well as human and murine keratinocytes are capable of expressing a family of recently described receptors termed Toll-like receptors (TLRs). To date, most published studies have examined the expression and function of TLR in leukocytes. Much less is known about the role of TLR in non-leukocytes such as keratinocytes. In this application we will utilize both an in vitro and in vivo murine model system to test the following hypotheses : 1) Keratinocyte TLR2 and TLR4 play an essential role in host cutaneous defenses to the gram (+) and gram (-) pathogens Staphylococcus aureus and Pseudomonas aeruginosa. 2) These protective anti-bacterial responses are mediated by activation of keratinocyte TLR2 and TLR4 by specific components of Staphylococcus aureus and Pseudomonas aeruginosa that initiate the local expression and production of potent antimicrobial innate immune effector proteins. 3) Defects in the expression or function of keratinocyte TLR2 and TLR4 will result in altered epidermal innate immune protective responses to S. aureus and P. aeruginosa that may lead to a progressive cutaneous infectious process causing increased morbidity and even death as a result of systemic spread of these bacterial pathogens. These hypotheses will be tested in the following specific aims: Specific Aim #1: To examine the expression and function of TLR2 and TLR4 in cultured murine keratinocytes in response to gram (+) and gram (-) bacteria, structural components derived from these bacteria, as well as selected proinflammatory and immunosuppressive agents. Specific Aim #2: To assess selected TLR2 and TLR4 mediated innate immune responses in cultured murine keratinocytes in response to pathogenic gram (+) and gram (-) bacteria and structural components derived from these bacteria. Specific Aim #3: To determine the in vivo role of murine keratinocyte TLR2 and TLR4 in mediating host protective epidermal innate immune responses to gram (+) and gram (-) bacterial infection and bacterial-derived components. Murine keratinocyte responses to pathogenic bacteria will be compared to responses to cutaneous commensal bacteria and confirmed in human keratinocytes. We believe that our studies will lead to novel insights into cutaneous innate immunity and the management of a wide range of inflammatory and infectious diseases in the skin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Keratinocyte TLR in Cutaneous Immunity
-
批准号:7479320
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2006
-
负责人:JOHN C ANSEL
-
依托单位:
Keratinocyte TLR in Cutaneous Immunity
-
批准号:7150977
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2006
-
负责人:JOHN C ANSEL
-
依托单位:
PROTEINASE ACTIVATED RECEPTORS IN CORNEAL INFLAMMATION
-
批准号:6547649
-
项目类别:
-
资助金额:$14.66万
-
财政年份:2002
-
负责人:JOHN C ANSEL
-
依托单位:
PROTEINASE ACTIVATED RECEPTORS IN CORNEAL INFLAMMATION
-
批准号:7085744
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2002
-
负责人:JOHN C ANSEL
-
依托单位:
PROTEINASE ACTIVATED RECEPTORS IN CORNEAL INFLAMMATION
-
批准号:6668508
-
项目类别:
-
资助金额:$14.61万
-
财政年份:2002
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION
-
批准号:6518627
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2000
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION
-
批准号:6801178
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2000
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION
-
批准号:6948385
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2000
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION
-
批准号:6642796
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2000
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION
-
批准号:2840475
-
项目类别:
-
资助金额:$26.8万
-
财政年份:2000
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION
-
批准号:6384802
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2000
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION
-
批准号:7085835
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2000
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF UV INDUCED CYTOKINES AND GROWTH FACTORS IN THE PATHOGENESIS OF PTERYGIUM
-
批准号:6268411
-
项目类别:
-
资助金额:$6.18万
-
财政年份:1998
-
负责人:JOHN C ANSEL
-
依托单位:
NEURO MICROVASCULAR MECHANISMS IN SKIN INFLAMMATION
-
批准号:2371937
-
项目类别:
-
资助金额:$17.84万
-
财政年份:1997
-
负责人:JOHN C ANSEL
-
依托单位:
NEURO MICROVASCULAR MECHANISMS IN SKIN INFLAMMATION
-
批准号:6679944
-
项目类别:
-
资助金额:$12.82万
-
财政年份:1997
-
负责人:JOHN C ANSEL
-
依托单位:
NEURO MICROVASCULAR MECHANISMS IN SKIN INFLAMMATION
-
批准号:2673024
-
项目类别:
-
资助金额:$18.38万
-
财政年份:1997
-
负责人:JOHN C ANSEL
-
依托单位:
NEURO MICROVASCULAR MECHANISMS IN SKIN INFLAMMATION
-
批准号:2887477
-
项目类别:
-
资助金额:$18.93万
-
财政年份:1997
-
负责人:JOHN C ANSEL
-
依托单位:
NEURO MICROVASCULAR MECHANISMS IN SKIN INFLAMMATION
-
批准号:6170457
-
项目类别:
-
资助金额:$19.5万
-
财政年份:1997
-
负责人:JOHN C ANSEL
-
依托单位:
NEURO MICROVASCULAR MECHANISMS IN SKIN INFLAMMATION
-
批准号:6373649
-
项目类别:
-
资助金额:$6.92万
-
财政年份:1997
-
负责人:JOHN C ANSEL
-
依托单位:
ROLE OF THE NEUROLOGIC SYSTEM IN WOUND HEALING
-
批准号:2206373
-
项目类别:
-
资助金额:$15.05万
-
财政年份:1994
-
负责人:JOHN C ANSEL
-
依托单位:
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
-
批准号:81971557
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:毛开睿
-
依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
-
批准号:51678163
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:许玫英
-
依托单位: